Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platelet Coagulation Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05237492
What this trial is testing

The Influence of Tramadol on Platelet Function

Who this might be right for
Drug ToxicityPlatelet DysfunctionClotting Disorder
Medical University of Graz 33
Not applicableLooking for participantsNCT04398628
What this trial is testing

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Who this might be right for
Hematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more
American Thrombosis and Hemostasis Network 3,000
Not applicableNot Yet RecruitingNCT07349134
What this trial is testing

WELL-MPN: A Digital Lifestyle App for Patients With MPNs

Who this might be right for
Myeloproliferative Neoplasms (MPNs)
Brigham and Women's Hospital 75
Not applicableLooking for participantsNCT07230067
What this trial is testing

Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）

Who this might be right for
SepsisSepsis and Coagulopathy
Nanfang Hospital, Southern Medical University 1,500
Post-approval studies (Phase 4)Study completedNCT01558739
What this trial is testing

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythaemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Not applicableStudy completedNCT02953704
What this trial is testing

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 1,469
Large-scale testing (Phase 3)Active Not RecruitingNCT04812925
What this trial is testing

Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 173
Not applicableStudy completedNCT02979158
What this trial is testing

Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass

Who this might be right for
Cardiopulmonary BypassPlatelet DisorderBleeding Disorder+1 more
Umeå University 60
Not applicableNot Yet RecruitingNCT07518940
What this trial is testing

ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia

Who this might be right for
Myeloproliferative DiseasePolycythemia VeraThrombocythemia Essential+2 more
Carmen Fava 25
Testing effectiveness (Phase 2)Study completedNCT00625443
What this trial is testing

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 53
Not applicableUnknownNCT05785468
What this trial is testing

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1
Early research (Phase 1)Active Not RecruitingNCT04041050
What this trial is testing

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm
AbbVie 85
Not applicableNot Yet RecruitingNCT07680010
What this trial is testing

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

Who this might be right for
Immune Thrombocytopenic Purpura ( ITP )Systemic Lupus Erythematosus (SLE)
University Hospital, Bordeaux 105
Testing effectiveness (Phase 2)UnknownNCT02757196
What this trial is testing

Treatment of ITP With Rituximab and / or Accutane

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 112
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableLooking for participantsNCT04645199
What this trial is testing

National Longitudinal Cohort of Hematological Diseases

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more
Institute of Hematology & Blood Diseases Hospital, China 2,300
Testing effectiveness (Phase 2)Study completedNCT00718692
What this trial is testing

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Symphogen A/S 61
Large-scale testing (Phase 3)Study completedNCT02973087
What this trial is testing

RVWF IN PROPHYLAXIS

Who this might be right for
Von Willebrand Disease
Takeda 29
Next Page